PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 130 filers reported holding PROVENTION BIO INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,257,241 | +53.9% | 176,649 | -32.5% | 0.00% | +100.0% |
| Q4 2022 | $2,765,714 | +5218.7% | 261,657 | +2174.5% | 0.00% | – |
| Q3 2022 | $52,000 | -98.2% | 11,504 | -97.1% | 0.00% | -100.0% |
| Q1 2022 | $2,863,000 | +280.7% | 391,061 | +192.0% | 0.00% | – |
| Q4 2021 | $752,000 | -36.9% | 133,932 | -28.0% | 0.00% | – |
| Q3 2021 | $1,191,000 | -59.0% | 186,110 | -46.0% | 0.00% | – |
| Q2 2021 | $2,906,000 | +742.3% | 344,805 | +947.8% | 0.00% | – |
| Q1 2021 | $345,000 | +13.5% | 32,909 | +83.6% | 0.00% | – |
| Q4 2020 | $304,000 | -77.2% | 17,924 | -82.7% | 0.00% | -100.0% |
| Q3 2020 | $1,333,000 | -48.8% | 103,857 | -43.8% | 0.00% | 0.0% |
| Q2 2020 | $2,605,000 | +310.9% | 184,639 | +168.0% | 0.00% | 0.0% |
| Q1 2020 | $634,000 | – | 68,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |